4
Changes in Ownership
RESMED INC Filed Acc 0001127602-24-022064
President, SaaS Business sold 10,000 shares at $216.60 ($2,166,000)
- President, SaaS Business acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ghoshal Kaushik · President, SaaS Business
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-12 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,086 | $95.80 | $199,839 | 15,118 | D |
| 2024-08-12 | Exercise or conversion : show line 2 in the form 10b5-1 | +6,877 | $95.80 | $658,817 | 21,995 | D |
| 2024-08-12 | Exercise or conversion : show line 3 in the form 10b5-1 | +1,037 | $101.64 | $105,401 | 23,032 | D |
| 2024-08-12 | Sale : show line 4 in the form 10b5-1 | −10,000 | $216.60 | $2,166,000 | 13,032 | D |
| Open-market sales · 10,000 sh · avg $216.60 · $2,166,000 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-08-12 | Exercise or conversion : show line 5 in the form 10b5-1 ResMed Common Stock Options | −2,086 | 0 | D |
| 2024-08-12 | Exercise or conversion : show line 6 in the form 10b5-1 ResMed Common Stock Options | −6,877 | 0 | D |
| 2024-08-12 | Exercise or conversion : show line 7 in the form 10b5-1 ResMed Common Stock Options | −1,037 | 9,260 | D |
Loading xslF345X05/form4.xml…